The FDA doesn't publish a pen testing checklist, but its guidance, 524B requirements, and reviewer expectations add up to one. Here's what medical device makers must cover before, during, and after the test.

R&D and GxP regulated environments have different risk profiles, compliance requirements, and testing constraints. Learn why a single unified pen test scope fails both and how to run dual-scope engagements efficiently.

Section 524B made medical device cybersecurity a legal requirement, not a guideline. Learn what the FDA expects from your pen test scope, evidence package, and postmarket vulnerability management process.

Annual penetration testing produces documentation, not security. Learn how Penetration Testing as a Service fits manufacturing's high-change OT environments and closes the gap between discovery and fix.

Ransomware operators target the IT-OT boundary deliberately and they know manufacturing economics well. Learn how attackers pivot from IT into OT systems and what penetration testing finds before they do.